Discovery promises new treatments to thwart colon cancer

19 junio 2015

Scientists have discovered how an immune system protein, called AIM2 (Absent in Melanoma 2), plays a role in determining the aggressiveness of colon cancer. They found that AIM2 deficiency causes uncontrolled proliferation of intestinal cells. Surprisingly, they also discovered that AIM2 influences the microbiota — the population of gut bacteria — apparently fostering the proliferation of ‘good’ bacteria that can protect against colon cancer.